Zhiping Li

机构：Sichuan University, West China Hospital of Sichuan University · ORCID：0000-0002-2292-2044

发表论文 34 篇 · 总被引 274 次 · h-index 8

代表论文

• Prevalence and Risk Factors of Self-Medication Among the Pediatric Population in China: A National Survey (2022 · Frontiers in Public Health · 被引 29)
• Spatial interactions of immune cells as potential predictors to efficacy of toripalimab plus chemotherapy in locally advanced or metastatic pancreatic ductal adenocarcinoma: a phase Ib/II trial (2024 · Signal Transduction and Targeted Therapy · 被引 25)
• S-1 plus Raltitrexed for Refractory Metastatic Colorectal Cancer: A Phase II Trial (2019 · The Oncologist · 被引 18)
• Efficacy and safety of surufatinib plus toripalimab, a chemotherapy-free regimen, in patients with advanced gastric/gastroesophageal junction adenocarcinoma, esophageal squamous cell carcinoma, or biliary tract cancer (2024 · Cancer Immunology Immunotherapy · 被引 17)
• TREM2 alleviates sepsis-induced acute lung injury by attenuating ferroptosis via the SHP1/STAT3 pathway (2025 · Free Radical Biology and Medicine · 被引 12)
• Initial Dosage Recommendation for Sirolimus in Children With Tuberous Sclerosis Complex (2020 · Frontiers in Pharmacology · 被引 12)